HIV clinic-based extended-release naltrexone versus treatment as usual for people with HIV and opioid use disorder: a non-blinded, randomized non-inferiority trial.
Saved in:
| Title: | HIV clinic-based extended-release naltrexone versus treatment as usual for people with HIV and opioid use disorder: a non-blinded, randomized non-inferiority trial. |
|---|---|
| Authors: | Korthuis PT; Addiction Medicine Program, Oregon Health and Science University, Portland, OR, USA.; Oregon Health and Science University-Portland State University School of Public Health, Portland, OR, USA., Cook RR; Addiction Medicine Program, Oregon Health and Science University, Portland, OR, USA., Lum PJ; Division of HIV, ID and Global Medicine, University of California, San Francisco, CA, USA., Waddell EN; Addiction Medicine Program, Oregon Health and Science University, Portland, OR, USA.; Oregon Health and Science University-Portland State University School of Public Health, Portland, OR, USA., Tookes H; Division of Infectious Diseases, University of Miami Miller School of Medicine, Miami, FL, USA., Vergara-Rodriguez P; Ruth M. Rothstein CORE Center, Department of Psychiatry and Department of Internal Medicine, Cook County Health, Chicago, IL, USA., Kunkel LE; Addiction Medicine Program, Oregon Health and Science University, Portland, OR, USA., Lucas GM; Johns Hopkins School of Medicine, Baltimore, MD, USA., Rodriguez AE; Division of Infectious Diseases, University of Miami Miller School of Medicine, Miami, FL, USA., Bielavitz S; Addiction Medicine Program, Oregon Health and Science University, Portland, OR, USA., Fanucchi LC; Division of Infectious Diseases and Center on Drug and Alcohol Research, University of Kentucky, Lexington, KY, USA., Hoffman KA; Oregon Health and Science University-Portland State University School of Public Health, Portland, OR, USA., Bachrach K; Tarzana Treatment Centers, Tarzana, CA, USA., Payne EH; Emmes Company, LLC, Rockville, MD, USA., Collins JA; Emmes Company, LLC, Rockville, MD, USA., Matthews A; Emmes Company, LLC, Rockville, MD, USA., Oden N; Emmes Company, LLC, Rockville, MD, USA., Jacobs P; National Institutes of Health, National Institute on Aging, Bethesda, MD, USA., Jelstrom E; Emmes Company, LLC, Rockville, MD, USA., Sorensen JL; Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, CA, USA., McCarty D; Addiction Medicine Program, Oregon Health and Science University, Portland, OR, USA.; Oregon Health and Science University-Portland State University School of Public Health, Portland, OR, USA. |
| Source: | Addiction (Abingdon, England) [Addiction] 2022 Jul; Vol. 117 (7), pp. 1961-1971. Date of Electronic Publication: 2022 Mar 02. |
| Publication Type: | Equivalence Trial; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9304118 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1360-0443 (Electronic) Linking ISSN: 09652140 NLM ISO Abbreviation: Addiction Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1360-0443 |
|---|---|
| DOI: | 10.1111/add.15836 |
